Validity of Glycated Hemoglobin in Screening and Diagnosing Type 2 Diabetes Mellitus in Chinese Subjects = Validity of Glycated Hemoglobin in Screening and Diagnosing Type 2 Diabetes Mellitus in Chinese Subjects

다국어 초록 (Multilingual Abstract)

Background/Aims: The application of glycated hemoglobin (HbA1c) for the diagnosis of diabetes is currently under extensive discussion. In this study, we explored the validity of using HbA1c as a screening and diagnostic test in Chinese subjects recruited in Nanjing, China. Methods: In total, 497 subjects (361 men and 136 women) with fasting plasma glucose (PG) ≥ 5.6 mmol/L were recruited to undergo the oral glucose tolerance test (OGTT) and HbA1c test. Plasma lipid, uric acid, and blood pressure were also measured. Results: Using a receiver operating characteristic curve, the optimal cutoff point of HbA1c related to diabetes diagnosed by the OGTT was 6.3%, with a sensitivity and specificity of 79.6% and 82.2%, respectively, and the area under the curve was 0.87 (95% confidence interval, 0.83 to 0.92). A HbA1c level of 6.5% had a sensitivity and specificity of 62.7% and 93.5%, respectively. When comparing the HbA1c ≥ 6.5% or OGTT methods for diagnosing diabetes, the former group had significantly higher HbA1c levels and lower levels of fasting and 2-hour PG than the latter group. No significant difference was observed in the other metabolism indexes between the two groups. Conclusions: Our results suggest that HbA1c ≥ 6.5% has reasonably good specificity for diagnosing diabetes in Chinese subjects, which is in concordance with the American Diabetes Association recommendations.

참고문헌 (Reference)

1 Manley SE, "Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations" 26 : 115-121, 2009

2 Buell C, "Utility of A1C for diabetes screening in the 1999-2004 NHANES population" 30 : 2233-2235, 2007

3 Gregg EW, "Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S" 27 : 2806-2812, 2004

4 Nathan DM, "Translating the A1C assay into estimated average glucose values" 31 : 1473-1478, 2008

5 Miedema K, "Towards worldwide standardisation of HbA1c determination" 47 : 1143-1148, 2004

6 Motta M, "The value of glycosylated hemoglobin (HbA1c) as a predictive risk factor in the diagnosis of diabetes mellitus (DM) in the elderly" 50 : 60-64, 2010

7 Ko GT, "The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors" 35 : 62-67, 1998

8 American Diabetes Association, "Standards of medical care in diabetes-2010" 33 (33): S11-S61, 2010

9 Selvin E, "Short-term variability in measures of glycemia and implications for the classification of diabetes" 167 : 1545-1551, 2007

10 Ganda OP, "Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests" 27 : 715-725, 1978

11 Sabanayagam C, "Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes?" 52 : 1279-1289, 2009

12 Nakagami T, "Is the measurement of glycated hemoglobin A1c alone an efficient screening test for undiagnosed diabetes? Japan National Diabetes Survey" 76 : 251-256, 2007

13 International Expert Committee, "International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes" 32 : 1327-1334, 2009

14 Herman WH, "Hemoglobin A1c for the diagnosis of diabetes: practical considerations" 120 : 37-40, 2010

15 Bennett CM, "HbA(1c) as a screening tool for detection of type 2 diabetes: a systematic review" 24 : 333-343, 2007

16 Friedewald WT, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge" 18 : 499-502, 1972

17 Herman WH, "Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program" 30 : 2453-2457, 2007

18 American Diabetes Association, "Diagnosis and classification of diabetes mellitus" 34 : S62-S69, 2011

19 Hu Y, "Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance" 47 : 231-236, 2010

20 Mohan V, "A1C cut points to define various glucose intolerance groups in Asian Indians" 33 : 515-519, 2010

21 Weykamp C, "A review of the challenge in measuring hemoglobin A1c" 3 : 439-445, 2009

22 Saudek CD, "A new look at screening and diagnosing diabetes mellitus" 93 : 2447-2453, 2008

23 Viberti G, "A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of type 2 diabetic patients in North America and Europe" 23 : 1289-1294, 2006